Femtogenix
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Britannia Trinity St, London, Greater Lo...Phone Number
+44 2038580153Website
www.femtogenix.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Femtogenix
Femtogenix discovers and develops next-generation DNA-interactive payload molecules for use in antibody-drug conjugates (ADCs). Its payloads are designed using a proprietary development platform combining computational chemistry techniques and know-how gained from decades of experience in DNA-targeted drug discovery and development. This unique platform enables Femtogenix to design molecules capable of binding reversibly and/or irreversibly to DNA in a sequence-selective manner, resulting in exquisite tumour cell cytotoxicity. When attached to antibodies or other targeting moieties, these potent cytotoxic agents can be delivered directly to tumours with minimal systemic toxicities. Based in Harpenden in the UK, Femtogenix works with a variety of partners to produce novel ADC anticancer therapies.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Femtogenix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Femtogenix has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Femtogenix had a recent Job posting/layoffs
Femtogenix, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Femtogenix recently announced quarterly report
Funding: Get notified immidiatlly once Femtogenix has new funding data
Check out if Femtogenix is spiking on competitors!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Femtogenix
Product Launch: Get notified when Femtogenix launches new products
Recommended Actions
Find VP level buyers at Femtogenix
Find more new buyers
Compare Similar Companies to Femtogenix
Compare insights from companies similar to Femtogenix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Femtogenix
<$5M
11-50
Private
-
2015
N/A
Company Profile Activity
Activity Insights
Femtogenix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Femtogenix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Femtogenix.
Femtogenix Tech Stack
A closer look at the technologies used by Femtogenix
See more technologies
Femtogenix News & Media
Femtogenix Presents Efficacy and Toxicity Data on Antibody Drug Conjugates Containing New Generation of DNA-binding Therapeutic Payloads
HARPENDEN, England--(BUSINESS WIRE)--Femtogenix Ltd, a UK biotechnology company developing the next generation of DNA-interactive Antibody Drug Conjugate (ADC) payloads, today announced data verifying the favourable toxicity profile and potent efficacy of its Pyridinobenzodiazepine (PDD) ADC payload platform in tumour cell models. The data was presented by Professor David Thurston, Chief Scientific Officer, Femtogenix, on 11 October at World ADC 2019 in San Diego, CA. ADCs are capable of deliveFemtogenix Presents Data at AACR Annual Meeting 2018 Showing High Potency of Its New Generation DNA-Binding Payloads in Antibody Drug Conjugates
WELWYN GARDEN CITY, United Kingdom, and CHICAGO, April 12, 2018 /PRNewswire/ -- Femtogenix, Ltd, a UK biotechnology company pioneering the next generation of DNA-interactive Antibody Drug Conjugate (ADC) payloads, today announced it will present data highlighting the high potency of its...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Femtogenix
Sign Up For FreeTo access detailed company insights
Femtogenix discovers and develops next-generation DNA-interactive payload molecules for use in antibody-drug conjugates (ADCs). Its payloads are designed using a proprietary development platform combining computational chemistry techniques and know-how gained from decades of experience in DNA-targeted drug discovery and development. This unique pla... Read More
